Attached files

file filename
8-K - 8-K - KEMET CORPa11-11658_18k.htm
EX-99.2 - EX-99.2 - KEMET CORPa11-11658_1ex99d2.htm

Exhibit 99.1

 

 

FOR IMMEDIATE RELEASE

 

Contact:

William M. Lowe, Jr.

Dean W. Dimke

 

Executive Vice President and

Director of Corporate and

 

Chief Financial Officer

Investor Communications

 

williamlowe@KEMET.com

deandimke@KEMET.com

 

864-963-6484

954-766-2800

 

KEMET REPORTS FOURTH QUARTER AND FISCAL YEAR 2011 FINANCIAL RESULTS

 

-Net sales of $261.5 million for the March 2011 quarter up 22.8% compared to prior year fourth quarter

-Net sales of $1.018 billion for the fiscal year ended March 2011 up 38.3% compared to prior fiscal year

-Cash and cash equivalents of $152.1 million at March 31, 2011 up from $79.2 million at March 31, 2010

-Adjusted EBITDA of $196.1 million for the fiscal year ended March 31, 2011

-GAAP net income per diluted share for the fourth quarter and fiscal year 2011 was $0.40, and $1.22, respectively

-Non-GAAP net income per diluted share for the fourth quarter and fiscal year 2011 was $0.49, and $2.22, respectively

 

Greenville, South Carolina (May 12, 2011) - KEMET Corporation (NYSE: KEM) today reported preliminary results for the fourth fiscal quarter ended March 31, 2011.  Net sales for the quarter ended March 31, 2011 were $261.5 million, which is a 22.8% increase over the same quarter last fiscal year.

 

On a U.S. GAAP basis, net income was $21.1 million, or $0.40 per diluted share for the fourth quarter of fiscal year 2011 compared to net income of $0.3 million or $0.01 per diluted share for the same quarter last year. The current fiscal quarter includes $2.0 million of restructuring charges primarily associated with the relocation of equipment, a $3.0 million inventory adjustment and $0.6 million of debt and stock registration related fees.  The fourth quarter of fiscal year 2010 included $6.6 million of restructuring charges and a $1.5 million net gain on sales and disposals of assets.

 

Non-GAAP adjusted net income was $25.6 million or $0.49 per diluted share for the current fiscal quarter compared to a $6.8 million adjusted net income or $0.14 per diluted share for the same quarter last year.

 

“Our revenue remained strong and exceeded expectations in the last quarter of our year with revenue surpassing one billion dollars for our full fiscal year,” said Per Loof KEMET’s Chief Executive Officer.  “Our accomplishments on cost containment over the past year have continued to benefit our operating results and we expect that margins will hold in the near-term at or above our fourth quarter results despite rising raw material prices.  We remain optimistic about the industry trend and demand for our products in all of our geographic regions and we remain focused on creating additional value as we begin our next fiscal year,” continued Loof.

 

For the fiscal year ended March 31, 2011, net sales were $1,018.5 million up from $736.3 million in the prior fiscal year.  On a U.S. GAAP basis, net income for the year was $63.0 million, or $1.22 per diluted share, compared to a net loss of $69.4 million, or $ (2.57) per share, for the fiscal year ended March 31, 2010.  Non-GAAP net income was $114.2 million, or $2.22 per diluted share for the fiscal year ended March 31, 2011 compared to a net income of $2.6 million or $0.10 per diluted share for the fiscal year ended March 31, 2010.

 



 

About KEMET

 

The Company’s common stock is listed on the NYSE under the ticker symbol ‘KEM’ (NYSE: KEM).  At the Investor Relations section of our web site at http://www.KEMET.com/IR, users may subscribe to KEMET news releases and find additional information about our Company.  KEMET applies world class service and quality to deliver industry leading, high performance capacitance solutions to its customers around the world and offers the world’s most complete line of surface mount and through hole capacitor technologies across tantalum, ceramic, film, aluminum, electrolytic, and paper dielectrics. Additional information about KEMET can be found at http://www.kemet.com.

 

QUIET PERIOD

 

Beginning July 1, 2011, we will observe a quiet period during which the information provided in this news release and our annual report on Form 10-K will no longer constitute our current expectations. During the quiet period, this information should be considered to be historical, applying prior to the quiet period only and not subject to update by management. The quiet period will extend until the day when our next quarterly earnings release is published.

 

CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

 

Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about KEMET Corporation’s (the “Company”) financial condition and results of operations that are based on management’s current expectations, estimates and projections about the markets, in which the Company operates, as well as management’s beliefs and assumptions. Words such as “expects,” “anticipates,” “believes,” “estimates,” variations of such words and other similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise.

 

Factors that may cause actual outcome and results to differ materially from those expressed in, or implied by, these forward-looking statements include, but are not necessarily limited to the following:

 

(i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate; (ii) adverse economic conditions could cause the write down of long-lived assets; (iii) an increase in the cost or a decrease in the availability of our principal raw materials; (iv) changes in the competitive environment; (v) uncertainty of the timing of customer product qualifications in heavily regulated industries; (vi) economic, political, or regulatory changes in the countries in which we operate; (vii) difficulties, delays or unexpected costs in completing the restructuring plan; (viii) inability to attract, train and retain effective employees and management; (ix) inability to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (x) exposure to claims alleging product defects; (xi) the impact of laws and regulations that apply to our business, including those relating to environmental matters; (xii) volatility of financial and credit markets affecting our access to capital;  (xiii) needing to reduce the total costs of our products to remain competitive; (xiv) potential limitation on the use of net operating losses to offset possible future taxable income; (xv) exercise of the warrant by K Equity which could potentially may result in the existence of a significant stockholder who could seek to influence our corporate decisions; and (xvi) recent events in Japan could negatively impact our sales and supply chain.

 

2



 

KEMET CORPORATION AND SUBSIDIARIES

Consolidated Statements of Operations

(Amounts in thousands except per share data)

(Unaudited)

 

 

 

Quarters Ended

 

Fiscal Years Ended

 

 

 

March 2011

 

March 2010

 

March 2011

 

March 2010

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

261,452

 

$

212,980

 

$

1,018,488

 

$

736,335

 

 

 

 

 

 

 

 

 

 

 

Operating costs and expenses:

 

 

 

 

 

 

 

 

 

Cost of sales

 

198,958

 

169,556

 

752,846

 

611,638

 

Selling, general and administrative expenses

 

27,940

 

25,388

 

104,607

 

86,085

 

Research and development

 

6,662

 

6,079

 

25,864

 

22,064

 

Restructuring charges

 

1,974

 

6,609

 

7,171

 

9,198

 

Net (gain) loss on sales and disposals of assets

 

145

 

(1,501

)

(1,261

)

(1,003

)

Write down of long-lived assets

 

 

 

 

656

 

Total operating costs and expenses

 

235,679

 

206,131

 

889,227

 

728,638

 

Operating income

 

25,773

 

6,849

 

129,261

 

7,697

 

 

 

 

 

 

 

 

 

 

 

Other (income) expense:

 

 

 

 

 

 

 

 

 

Interest income

 

(85

)

(41

)

(218

)

(188

)

Interest expense and amortization of debt discount

 

7,627

 

6,264

 

30,175

 

26,008

 

Other (income) expense, net

 

(3,045

)

(2,078

)

(4,692

)

4,121

 

(Gain) loss on early extinguishment of debt

 

 

 

38,248

 

(38,921

)

Increase in value of warrant

 

 

 

 

81,088

 

Income (loss) before income taxes

 

21,276

 

2,704

 

65,748

 

(64,411

)

Income tax expense

 

211

 

2,387

 

2,704

 

5,036

 

Net income (loss)

 

$

21,065

 

$

317

 

$

63,044

 

$

(69,447

)

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share (basic)

 

$

0.57

 

$

0.01

 

$

2.11

 

$

(2.57

)

Net income (loss) per share (diluted)

 

$

0.40

 

$

0.01

 

$

1.22

 

$

(2.57

)

 

 

 

 

 

 

 

 

 

 

Weighted-average shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

37,127

 

27,017

 

29,847

 

26,971

 

Diluted

 

52,293

 

47,679

 

51,477

 

26,971

 

 

3



 

KEMET CORPORATION AND SUBSIDIARIES

Consolidated Balance Sheets

(Amounts in thousands, except per share data)

 

 

 

March 31,

 

 

 

2011

 

2010

 

 

 

(Unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

152,051

 

$

79,199

 

Accounts receivable, net

 

160,708

 

137,385

 

Inventories, net

 

206,440

 

150,508

 

Prepaid and other current assets

 

18,020

 

18,790

 

Deferred income taxes

 

5,301

 

2,129

 

Total current assets

 

542,520

 

388,011

 

Property, plant and equipment, net

 

310,412

 

319,878

 

Intangible assets, net

 

20,092

 

21,806

 

Other assets

 

11,285

 

11,266

 

Total assets

 

$

884,309

 

$

740,961

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Current portion of long-term debt

 

$

42,101

 

$

17,880

 

Accounts payable

 

90,997

 

78,829

 

Accrued expenses

 

88,291

 

63,606

 

Income taxes payable

 

4,265

 

1,096

 

Total current liabilities

 

225,654

 

161,411

 

Long-term debt

 

231,215

 

231,629

 

Other non-current obligations

 

59,727

 

55,626

 

Deferred income taxes

 

7,960

 

8,023

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Common stock, par value $0.01, authorized 300,000 shares, issued 39,508 and 29,508 shares at March 31, 2011 and 2010, respectively

 

395

 

295

 

Additional paid-in capital

 

479,322

 

479,705

 

Retained deficit

 

(87,745

)

(150,789

)

Accumulated other comprehensive income

 

22,555

 

11,990

 

Treasury stock, at cost (2,370 and 2,463 shares at March 31, 2011 and 2010, respectively)

 

(54,774

)

(56,929

)

Total stockholders’ equity

 

359,753

 

284,272

 

Total liabilities and stockholders’ equity

 

$

884,309

 

$

740,961

 

 

4



 

KEMET CORPORATION AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(Amounts in thousands)

(Unaudited)

 

 

 

Fiscal Years Ended March 31,

 

 

 

2011

 

2010

 

2009

 

Sources (uses) of cash and cash equivalents

 

 

 

 

 

 

 

Operating activities:

 

 

 

 

 

 

 

Net income (loss)

 

$

63,044

 

$

(69,447

)

$

(285,209

)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

52,932

 

52,644

 

58,125

 

Amortization of debt discount and debt issuance costs

 

4,930

 

13,392

 

9,918

 

Net gain on sales and disposals of assets

 

(1,261

)

(1,003

)

(25,505

)

Stock-based compensation expense

 

1,783

 

1,865

 

1,070

 

Pension and other post-retirement benefits

 

(2,319

)

(2,716

)

(3,742

)

Deferred income taxes

 

(3,403

)

2,051

 

(8,146

)

(Gain) loss on early extinguishment of debt

 

38,248

 

(38,921

)

 

Write down of long-lived assets

 

 

656

 

67,624

 

Goodwill impairment

 

 

 

174,327

 

Increase in value of warrant

 

 

81,088

 

 

Curtailment gains on benefit plans

 

 

 

(30,835

)

Other, net

 

(2,446

)

339

 

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable

 

(14,466

)

(18,263

)

44,777

 

Inventories

 

(48,817

)

7,168

 

71,308

 

Prepaid expenses and other current assets

 

(6,647

)

(5,647

)

4,055

 

Accounts payable

 

9,567

 

26,605

 

(67,356

)

Accrued income taxes

 

4,315

 

421

 

(490

)

Other operating liabilities

 

18,508

 

4,388

 

(4,196

)

Net cash provided by operating activities

 

113,968

 

54,620

 

5,725

 

 

 

 

 

 

 

 

 

Investing activities:

 

 

 

 

 

 

 

Capital expenditures

 

(34,989

)

(12,921

)

(30,541

)

Proceeds from sales of assets

 

5,425

 

1,500

 

34,870

 

Acquisitions, net of cash received

 

 

 

(1,000

)

Change in restricted cash

 

 

 

3,900

 

Net cash provided by (used in) investing activities

 

(29,564

)

(11,421

)

7,229

 

 

 

 

 

 

 

 

 

Financing activities:

 

 

 

 

 

 

 

Proceeds from issuance of debt

 

227,525

 

58,949

 

16,190

 

Payment of long-term debt

 

(230,413

)

(54,525

)

(67,949

)

Net (payments) borrowings under other credit facilities

 

(2,479

)

475

 

(411

)

Debt issuance costs

 

(7,853

)

(4,206

)

(1,574

)

Debt extinguishment costs

 

(207

)

(3,605

)

 

Proceeds from exercise of stock options

 

89

 

 

 

Other

 

 

 

249

 

Net cash used in financing activities

 

(13,338

)

(2,912

)

(53,495

)

Net increase (decrease) in cash and cash equivalents

 

71,066

 

40,287

 

(40,541

)

Effect of foreign currency fluctuations on cash

 

1,786

 

(292

)

(1,638

)

Cash and cash equivalents at beginning of fiscal year

 

79,199

 

39,204

 

81,383

 

Cash and cash equivalents at end of fiscal year

 

$

152,051

 

$

79,199

 

$

39,204

 

 

5



 

Non-U.S. GAAP Financial Measures

 

In this news release, the Company makes reference to certain Non-U.S. GAAP financial measures, including “Adjusted net income”, “Adjusted net income per share” and “Adjusted EBITDA”.  Management believes that investors may find it useful to review the Company’s financial results as adjusted to exclude items as determined by management.

 

Adjusted Net Income and Adjusted Net Income Per Share

 

“Adjusted net income” and “Adjusted net income per share” represent net income/loss and net income/loss per share excluding increase in value of warrant, gain/loss on early extinguishment of debt, ERP integration costs, restructuring charges related primarily to equipment moves and employee severance, gain/loss on sales and disposals of assets, amortization related to debt issuance costs and debt discount, debt and stock registration related fees, cancellation of incentive plan, write down of long-lived assets, net foreign exchange gain/loss, stock-based compensation expense, write off of capitalized advisor fee and gain on licensing of patents.  Management believes that these Non-U.S. GAAP financial measures are useful to investors because they provide a supplemental way to understand the underlying operating performance of the Company.  Management uses these Non-U.S. GAAP financial measures to evaluate operating performance.  Non-U.S. GAAP financial measures should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP.

 

The following table provides reconciliation from U.S. GAAP net income/loss to Non-U.S. GAAP adjusted net income/loss:

 

GAAP to Non-GAAP Reconciliation

(Unaudited)

 

 

 

Quarters Ended

 

Fiscal Years Ended

 

 

 

March 2011

 

December 2010

 

March 2010

 

March 2011

 

March 2010

 

 

 

(Amounts in thousands, except per share data)

 

Including adjustments (GAAP)

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

261,452

 

$

264,654

 

$

212,980

 

$

1,018,488

 

$

736,335

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

21,065

 

$

27,167

 

$

317

 

$

63,044

 

$

(69,447

)

Net income (loss) per share (basic)

 

$

0.57

 

$

0.96

 

$

0.01

 

$

2.11

 

$

(2.57

)

Net income (loss) per share (diluted)

 

$

0.40

 

$

0.52

 

$

0.01

 

$

1.22

 

$

(2.57

)

 

 

 

 

 

 

 

 

 

 

 

 

Excluding the following items (Non-GAAP)

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

21,065

 

$

27,167

 

$

317

 

$

63,044

 

$

(69,447

)

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

Restructuring charges 

 

1,974

 

1,102

 

6,609

 

7,171

 

9,198

 

Net foreign exchange (gain) loss

 

(3,266

)

1,785

 

(2,093

)

(2,888

)

4,106

 

Inventory write-downs 

 

2,991

 

 

 

2,991

 

 

Amortization included in interest expense

 

966

 

1,210

 

3,806

 

4,930

 

13,392

 

Stock-based compensation expense

 

872

 

429

 

77

 

1,783

 

1,865

 

ERP integration costs

 

658

 

602

 

 

1,915

 

 

Debt and stock registration related fees

 

581

 

950

 

 

1,531

 

 

(Gain) loss on sales and disposals of assets

 

145

 

29

 

(1,501

)

(1,261

)

(1,003

)

(Gain) loss on early extinguishment of debt

 

 

 

 

38,248

 

(38,921

)

Gain on licensing of patents 

 

 

 

 

(2,000

)

 

Increase in value of warrant

 

 

 

 

 

81,088

 

Charge related to cancellation of an incentive plan

 

 

 

 

 

1,161

 

Write down of long lived assets

 

 

 

 

 

656

 

Write off of capitalized advisor fees

 

 

 

 

 

413

 

Income tax effect of non-GAAP adjustments (1)

 

(428

)

(196

)

(462

)

(1,256

)

65

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted net income (excluding adjustments)

 

$

25,558

 

$

33,078

 

$

6,753

 

$

114,208

 

$

2,573

 

Adjusted net income per basic share (excluding adjustments)

 

$

0.69

 

$

1.17

 

$

0.25

 

$

3.83

 

$

0.10

 

Adjusted net income per diluted share (excluding adjustments)

 

$

0.49

 

$

0.64

 

$

0.14

 

$

2.22

 

$

0.10

 

 


(1)  The income tax effect of the excluded items is calculated by applying the applicable jurisdictional income tax rate, considering the deferred tax valuation for each applicable jurisdiction.

 

6



 

Adjusted EBITDA

 

Adjusted EBITDA represents net income/loss before income tax expense, net interest expense, and depreciation and amortization expense, adjusted to exclude: restructuring charges, stock-based compensation expense, debt and stock registration related fees, gain/loss on sales and disposals of assets, write down of long-lived assets, gain/loss on early extinguishment of debt, ERP integration costs, net foreign exchange gain/loss, inventory write-downs, increase in value of warrant and gain on licensing of patents.  We use Adjusted EBITDA to monitor and evaluate our operating performance and to facilitate internal and external comparisons of the historical operating performance of our business.  We present Adjusted EBITDA as a supplemental measure of our performance and ability to service debt.  We also present Adjusted EBITDA because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.

 

We believe Adjusted EBITDA is an appropriate supplemental measure of debt service capacity, because cash expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other items excluded from Adjusted EBITDA are excluded in order to better reflect our continuing operations.

 

In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments noted below.  Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these types of adjustments.  Adjusted EBITDA is not a measurement of our financial performance under U.S. GAAP and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity.

 

Our Adjusted EBITDA measure has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under U.S. GAAP.  Some of these limitations are:

 

·                  it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;

 

·                  it does not reflect changes in, or cash requirements for, our working capital needs;

 

·                  it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt;

 

·                  although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our Adjusted EBITDA measure does not reflect any cash requirements for such replacements;

 

·                  it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;

 

·                  it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations;

 

·                  it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and

 

·                  other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure.

 

Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations.  You should compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only supplementally.

 

7



 

The following tables provide reconciliation from U.S. GAAP net income (loss) to Adjusted EBITDA (amounts in thousands):

 

 

 

Fiscal Year 2011

 

 

 

Q1

 

Q2

 

Q3

 

Q4

 

Total

 

Net income (loss)

 

$

(20,099

)

$

34,911

 

$

27,167

 

$

21,065

 

$

63,044

 

Income tax expense

 

1,275

 

593

 

625

 

211

 

2,704

 

Interest expense, net

 

7,437

 

7,250

 

7,728

 

7,542

 

29,957

 

Depreciation and amortization expense

 

14,510

 

14,132

 

12,661

 

11,629

 

52,932

 

Stock-based compensation expense

 

149

 

333

 

429

 

872

 

1,783

 

Net foreign exchange (gain) loss

 

1,272

 

(2,679

)

1,785

 

(3,266

)

(2,888

)

ERP integration costs

 

280

 

375

 

602

 

658

 

1,915

 

(Gain) loss on sales and disposals of assets

 

335

 

(1,770

)

29

 

145

 

(1,261

)

Restructuring charges

 

1,792

 

2,303

 

1,102

 

1,974

 

7,171

 

Loss on early extinguishment of debt

 

38,248

 

 

 

 

38,248

 

Gain on licensing of patents

 

 

(2,000

)

 

 

(2,000

)

Debt and stock registration related fees

 

 

 

950

 

581

 

1,531

 

Inventory write-downs

 

 

 

 

2,991

 

2,991

 

Adjusted EBITDA

 

$

45,199

 

$

53,448

 

$

53,078

 

$

44,402

 

$

196,127

 

 

 

 

Fiscal Year 2010

 

 

 

Q1

 

Q2

 

Q3

 

Q4

 

Total

 

Net income (loss)

 

$

25,090

 

$

(93,075

)

$

(1,779

)

$

317

 

$

(69,447

)

Income tax expense (benefit)

 

1,030

 

1,712

 

(93

)

2,387

 

5,036

 

Interest expense, net

 

5,788

 

6,389

 

7,420

 

6,223

 

25,820

 

Depreciation and amortization expense

 

12,264

 

13,226

 

13,701

 

13,453

 

52,644

 

Gain on early extinguishment of debt

 

(38,921

)

 

 

 

(38,921

)

Stock-based compensation expense

 

241

 

1,379

 

168

 

77

 

1,865

 

(Gain) loss on sales and disposals of assets

 

206

 

52

 

240

 

(1,501

)

(1,003

)

Net foreign exchange (gain) loss

 

4,221

 

1,416

 

562

 

(2,093

)

4,106

 

Restructuring charges

 

 

1,267

 

1,322

 

6,609

 

9,198

 

Increase in value of warrant

 

 

81,088

 

 

 

81,088

 

Write down of long-lived assets

 

 

 

656

 

 

656

 

Adjusted EBITDA

 

$

9,919

 

$

13,454

 

$

22,197

 

$

25,472

 

$

71,042

 

 

8